Prevention and Control of Influenza
Journal: Annals of Internal Medicine (1985)

Diagnosis and Treatment1 October 1985Prevention and Control of InfluenzaRecommendation of the Immunization Practices Advisory CommitteeAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-103-4-560 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractThese recommendations update for 1985-86 the information on the vaccine and antiviral agent available for control of influenza. Changes include addition of statements about the route of vaccine administration; the use of amantadine in medical personnel during influenza A outbreaks; the need to prepare contingency plans to expedite use of amantadine in aborting influenza A outbreaks among residents of institutions; and reduction in the dosage of amantadine for older patients or persons with seizure disorders.Selected Bibliography1. BARKER W and MULLOOLY J. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 1980;244:2547-9. CrossrefMedlineGoogle Scholar2. BARKER W and MULLOOLY J. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112:798-811. CrossrefMedlineGoogle Scholar3. BARKER W and MULLOOLY J. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982;142:85-9. CrossrefMedlineGoogle Scholar4. BUKOWSKYJ M, MUNT P, WIGLE R, and NAKATSU K. Theophylline clearance: lack of effect of influenza vaccination and ascorbic acid. Am Rev Respir Dis. 1984;129:672-5. CrossrefMedlineGoogle Scholar5. . Amantadine: does it have a role in prevention and treatment of influenza?: a National Institutes of Health Consensus Development Conference. Ann Intern Med. 1980;92:256-8. LinkGoogle Scholar6. DESTEFANO F, GOODMAN R, NOBLE G, MCCLARY G, SMITH S, and BROOME C. Simultaneous administration of influenza and pneumococcal vaccines. JAMA. 1982;247:2551-4. CrossrefGoogle Scholar7. DOLIN R, REICHMAN R, MADORE H, MAYNARD R, LINTON P, and WEBBER-JONES J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982;307:580-4. CrossrefMedlineGoogle Scholar8. DOWDLE W, COLEMAN M, and GREGG M. Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol. 1974;17:91-135. MedlineGoogle Scholar9. EICKHOFF T. Immunization against influenza: rationale and recommendations. J Infect Dis. 1971;123:446-54. CrossrefMedlineGoogle Scholar10. FEDSON D and KESSLER H. A hospital-based influenza immunization program, 1977-78. Am J Public Health. 1983;73:442-5. CrossrefMedlineGoogle Scholar11. GALASSO G, TYERYAR F, and CATE T, eds. Clinical studies of influenza vaccines—1976. J Infect Dis. 1977;136(suppl): S341-S742. Google Scholar12. GLEZEN W. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25-44. CrossrefMedlineGoogle Scholar13. HAMMOND G and CHEANG M. Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. Can Med Assoc J. 1984;131:449-52. MedlineGoogle Scholar14. HORADAM V, SHARP J, SMILACK J, and SCHONBERGER L. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med. 1981;94:454-8. LinkGoogle Scholar15. KAPLAN J, KATONA P, HURWITZ E, and SCHONBERGER L. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-81: Lack of an association with influenza vaccination. JAMA. 1982;248:698-700. CrossrefMedlineGoogle Scholar16. KILBOURNE E ed. The Influenza Viruses and Influenza. New York: Academic Press: 1975. Google Scholar17. LA MONTAGNE J, NOBLE G, and QUINNAN G. Summary of clinical trials of inactivated influenza vaccine-1978. Rev Infect Dis. 1983;5:723-36. CrossrefMedlineGoogle Scholar18. MUFSON M, KRAUSE H, TARRANT C, SCHIFFMAN G, and CANO F. Polyvalent pneumococcal vaccine given alone and in combination with bivalent influenza vaccine. Proc Soc Exp Biol Med. 1980;163:498-503. CrossrefMedlineGoogle Scholar19. NOLAN T, GOODMAN R, HINMAN A, NOBLE G, KENDAL A, and THACKER S. Morbidity and mortality associated with influenza B in the United States, 1979-80: a report from the Centers for Disease Control. J Infect Dis. 1980;142:360-2. CrossrefMedlineGoogle Scholar20. PATRIARCA P, KENDAL A, STRICOF R, WEBER J, MEISSNER M, and DATENO B. Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents [Letter]. N Engl J Med. 1983;308:1601-2. CrossrefMedlineGoogle Scholar21. PATRIARCA P, WEBER J, and PARKER R. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985;253:1136-9. CrossrefMedlineGoogle Scholar22. PARKMAN P, GALASSO G, TOP F, and NOBLE G. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration: summary of clinical trials of influenza vaccines. J Infect Dis. 1976;134:100-7. CrossrefGoogle Scholar23. WRIGHT P, DOLIN R, and LA MONTAGNE J. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration: summary of clinical trials of influenza vaccines—II. J Infect Dis. 1976;134:633-8. CrossrefMedlineGoogle Scholar24. YOUNKIN S, BETTS R, ROTH F, and DOUGLAS R. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine. Antimicrob Agents Chemother. 1983;23:577-82. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure Information▸From the Immunization Practices Advisory Committee, Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byLiver involvement in severe human influenza A H1N1Antiviral agentsChronic Obstructive Airways DiseaseCurrent immunization practicesAugmentation of Influenza Antibody Response in Elderly Men by Thymosin Alpha OneInfluenza vaccination in the elderly: improved antibody response with imuthiol (NA diethyldithiocarbamate) adjuvant therapyRapid detection of influenza virus in cell culture by indirect immunoperoxidase staining with type-specific monoclonal antibodiesAmantadine for Prophylaxis against Influenza ARapid detection of influenza virus by shell vial assay with monoclonal antibodies 1 October 1985Volume 103, Issue 4Page: 560-565KeywordsAntiviralsEpilepsyMedical staffVaccines ePublished: 1 December 2008 Issue Published: 1 October 1985 PDF downloadLoading ...